Filed 3.1y ago· Apr 17, 2023
17 days to disclose
Daniel S. Goldman
DHouseNew York-10
↑bought
CJPRY
$15K-$50K
−85.9% vs S&P 500
Trade dateMar 31, 2023
Unsponsored ADR
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | CJPRY Unsponsored ADR | Mar 31, 2023 17 days to disclose | Bad buy·−$845-2.6% −85.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Delta Air Lines DAL | Mar 31, 2023 17 days to disclose | Flat·+0.0% +72.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | B BDNNY | Mar 31, 2023 17 days to disclose | Good buy·+$3.8K+47.2% −36.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | BOC Hong Kong BHKLY | Mar 31, 2023 17 days to disclose | Good buy·+$6.9K+86.6% +3.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | CHGCY Unsponsored ADR | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | H HXGBY Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | James Hardie JHX Depositary Shares | Mar 31, 2023 17 days to disclose | Bad buy·−$200-2.5% −85.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | American Depository Receipt JAPAY Depository Receipt | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Vodafone Group Public VOD ten Ordinary Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Mitsubishi Ufj Financial MUFG | Mar 31, 2023 17 days to disclose | Flat·+0.0% +61.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Unum Group UNM | Mar 31, 2023 17 days to disclose | Flat·+0.0% +61.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Sea Ltd. SE Ordinary Share | Mar 31, 2023 17 days to disclose | Good buy·+$371+4.6% −78.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | ATLAS COPCO AB A S/ ATLKY Class A | Mar 31, 2023 17 days to disclose | Good buy·+$4.6K+56.9% −26.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | ASX Ltd ASXFY | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Inc MSADY Inc. Unsponsored ADR | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | MONOY Unsponsored ADR | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Activision Blizzard ATVI Activision Blizzard ⚑ Technology · Homeland Security | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | MSLOY ADR | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | R RHHBY Depositary Shares | Mar 31, 2023 17 days to disclose | Good buy·+$3.5K+44.0% +29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Mizuho Financial Group MFG Sponosred ADR | Mar 31, 2023 17 days to disclose | Good buy·+$16.8K+209.9% +148.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Banco Santander, S.a. SAN | Mar 31, 2023 17 days to disclose | Good buy·+$19K+237.4% +154.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | BAYRY Depositary Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | adidas AG ADDYY | Mar 31, 2023 17 days to disclose | Good buy·+$92+1.2% −82.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Enphase Energy ENPH | Mar 31, 2023 17 days to disclose | Bad buy·−$6.6K-83.0% −122.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Sumitomo Mitsui Financial Group SMFG Shares | Mar 31, 2023 17 days to disclose | Good buy·+$13.6K+170.0% +108.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Sunrun RUN | Mar 31, 2023 17 days to disclose | Bad buy·−$2.4K-30.0% −113.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Mosaic MOS | Mar 31, 2023 17 days to disclose | Bad buy·−$11.1K-49.4% −61.3% vs S&P 500 | $15K-$30K midpoint $22.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | MITEY Depositary Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Blink Charging BLNK | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | B BNPQY Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Rentokil Initial PLC RTO Depositary Shares | Mar 31, 2023 17 days to disclose | Bad buy·−$594-7.4% −90.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Ericsson Lm Telephone ERIC share | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Grifols Sa GRFS Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | T TOTDY Shares | Mar 31, 2023 17 days to disclose | Good buy·+$2.3K+28.6% −54.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | T TRUMY | Mar 31, 2023 17 days to disclose | Bad buy·−$629-7.9% −91.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | SYMRISE AG UNSP/ SYIEY | Mar 31, 2023 17 days to disclose | Bad buy·−$1.5K-18.4% −101.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | S SWDBY | Mar 31, 2023 17 days to disclose | Good buy·+$9.4K+117.7% +34.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | S SFTBY | Mar 31, 2023 17 days to disclose | Good buy·+$99.2K+305.1% +221.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Snowflake SNOW ⚑ Technology · Homeland Security | Mar 31, 2023 17 days to disclose | Good buy·+$15.3K+67.8% −77.4% vs S&P 500 | $15K-$30K midpoint $22.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Skanska AB SKBSY | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | SSDOY Depositary Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | S SGIOY | Mar 31, 2023 17 days to disclose | Good buy·+$2.8K+34.7% −48.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Seek Ltd SKLTY | Mar 31, 2023 17 days to disclose | Bad buy·−$3.1K-38.6% −122.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Seagen Inc SGEN Seagen | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | OTSKY Unsponsored ADR | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | N NTDTY | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | NOV Inc. NOV NOV | Mar 31, 2023 17 days to disclose | Good buy·+$3.5K+4.7% −35.0% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Nomura Resh Inst Ltd NRILY | Mar 31, 2023 17 days to disclose | Good buy·+$1.2K+14.4% −68.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Nokia NOK American Depositary Shares | Mar 31, 2023 17 days to disclose | Good buy·+$12.4K+155.0% +71.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Natwest Group PLC NWG Depositary Shares, | Mar 31, 2023 17 days to disclose | Good buy·+$44.6K+137.1% +53.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Mirati Therapeutics MRTX Mirati Therapeutics | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | MQBKY ADR | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | M&T Bank MTB | Mar 31, 2023 17 days to disclose | Good buy·+$6.5K+81.8% +20.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Lloyds Banking LYG Depositary Shares | Mar 31, 2023 17 days to disclose | Good buy·+$43.6K+134.1% +50.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Intercontinental Hotels IHG American Depositary Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +59.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Incyte INCY | Mar 31, 2023 17 days to disclose | Good buy·+$2.8K+34.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | HDELY ADR | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Genmab A/s GMAB Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Campbell's Company CPB Campbell Soup Company | Mar 31, 2023 17 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | WPP PLC WPP | Mar 31, 2023 17 days to disclose | Bad buy·−$5.5K-68.2% −151.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | FSUGY Depositary Shares | Mar 31, 2023 17 days to disclose | Flat·+0.0% +83.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | E EBKDY | Mar 31, 2023 17 days to disclose | Good buy·+$20.7K+258.7% +175.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Netflix NFLX | Mar 29, 2023 19 days to disclose | Flat·+0.0% +104.1% vs S&P 500 | $250K-$500K midpoint $375K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | CS Depositary Shares | Mar 20, 2023 28 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Philip Morris PM | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Zoetis ZTS | Mar 7, 2023 41 days to disclose | Bad buy·−$4.3K-54.3% −71.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Pfizer PFE | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Omega Healthcare Investors OHI | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | American Tower AMT | Mar 7, 2023 41 days to disclose | Flat·+0.0% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Brown & Brown BRO | Mar 7, 2023 41 days to disclose | Flat·+0.0% +47.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Caredx CDNA | Mar 7, 2023 41 days to disclose | Good buy·+$8.2K+102.3% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Danaher DHR | Mar 7, 2023 41 days to disclose | Bad buy·−$1.4K-18.1% −35.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Pfizer PFE | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Tyson Foods TSN | Mar 7, 2023 41 days to disclose | Good buy·+$1.3K+16.7% +0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Abbott Laboratories ABT | Mar 7, 2023 41 days to disclose | Bad buy·−$994-12.4% −29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Eli Lilly LLY | Mar 6, 2023 42 days to disclose | Good buy·+$18.5K+230.9% +215.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Coca-Cola KO | Mar 6, 2023 42 days to disclose | Good buy·+$2.5K+31.3% +16.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Charles Schwab SCHW | Mar 6, 2023 42 days to disclose | Good buy·+$6.6K+20.3% −23.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | UGI Corp. UGI UGI | Mar 6, 2023 42 days to disclose | Bad buy·−$1.1K-13.5% −99.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Aon PLC AON | Mar 6, 2023 42 days to disclose | Good buy·+$1.1K+3.5% −40.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Jazz Pharmaceuticals JAZZ Shares | Mar 6, 2023 42 days to disclose | Good buy·+$18.9K+58.1% +43.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Hawaiian Electric HE | Mar 6, 2023 42 days to disclose | Flat·+0.0% +35.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Zillow Group Z Stock | Mar 6, 2023 42 days to disclose | Good buy·+$1.6K+4.9% −10.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | PSEG PEG Incorporated | Mar 6, 2023 42 days to disclose | Flat·+0.0% +35.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | AbbVie ABBV | Mar 6, 2023 42 days to disclose | Good buy·+$3.2K+39.8% +24.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Ionis Pharmaceuticals IONS | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Biomarin Pharmaceutical BMRN | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | BlackRock BLK | Mar 6, 2023 42 days to disclose | Flat·+0.0% +43.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Equity Residential EQR Beneficial Interest | Mar 6, 2023 42 days to disclose | Good buy·+$1.9K+5.8% −10.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Dollar Tree DLTR | Mar 6, 2023 42 days to disclose | Bad buy·−$7.8K-24.1% −88.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Edwards Lifesciences EW | Mar 6, 2023 42 days to disclose | Good buy·+$2.1K+6.6% −8.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Bill Holdings BILL ⚑ Technology · Homeland Security | Mar 6, 2023 42 days to disclose | Flat·+0.0% +163.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Annaly Capital Management NLY | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | 3M MMM | Mar 6, 2023 42 days to disclose | Flat·+0.0% +68.4% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | AGNC Investment AGNC | Mar 6, 2023 42 days to disclose | Good buy·+$490+0.7% −15.2% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Alnylam Pharmaceuticals ALNY | Mar 6, 2023 42 days to disclose | Good buy·+$16.1K+49.6% +34.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Microsoft MSFT ⚑ Technology · Homeland Security | Mar 6, 2023 42 days to disclose | Good buy·+$5.3K+66.5% −96.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Crown Castle CCI | Mar 6, 2023 42 days to disclose | Bad buy·−$10K-30.7% −46.5% vs S&P 500 | $15K-$50K midpoint $32.5K |